Expression of FcRL3 on the surface of activated B cells enhances their sensitivity to signals from Toll-like receptors (particularly TLR9), which in turn intensifies the production of autoantibodies, including ACPA and RF—hallmarks of RA [24,33]. Here, FCRL3 is linked to rheumatoid arthritis.